Response to 'Evidence in Support of the Validity of the TNF Brake Hypothesis' by Maksymowych.
Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, , Herne, Germany.
Xenofon
X
Baraliakos
Jürgen
J
Braun
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab
Ankylosing Spondylitis; Inflammation; Magnetic Resonance Imaging